EyePoint Pharmaceuticals
EYPT
#5476
Rank
A$2.00 B
Marketcap
A$24.27
Share price
-4.98%
Change (1 day)
79.09%
Change (1 year)

Earnings for EyePoint Pharmaceuticals (EYPT)

Earnings in 2025 (TTM): -A$0.34 Billion

According to EyePoint Pharmaceuticals 's latest financial reports the company's current earnings are A$42.34 Million. In 2024 the company made an earning of -A$0.22 Billion a decrease over its 2023 earnings that were of -A$0.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for EyePoint Pharmaceuticals from 2003 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.34 Billion56.96%
2024 -A$0.22 Billion104.29%
2023 -A$0.11 Billion-29.88%
2022 -A$0.15 Billion87.2%
2021 -A$79.13 Million38.58%
2020 -A$57.1 Million-24.56%
2019 -A$75.69 Million
2017 -A$34.52 Million22.59%
2016 -A$28.16 Million-8.02%
2015 -A$30.62 Million-296.09%
2014 A$15.61 M-174.02%
2013 -A$21.09 Million37.42%
2012 -A$15.35 Million-56.29%
2011 -A$35.12 Million-1062.38%
2010 A$3.64 M-250.43%
2009 -A$2.43 Million-89.5%
2008 -A$23.11 Million
2005 -A$14.25 Million56.99%
2004 -A$9.08 Million73.7%
2003 -A$5.23 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NRC Health
NRC
A$41.22 M-112.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
-A$3.24 Million-98.99% Bahamas